Dr. Pavan Bhargava, MD

Dr. Bhargava practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Bhargava's NPI, 1326270174, was assigned on August 12, 2009. Dr. Bhargava holds Maryland license D0080405.

Dr. Bhargava's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Bhargava's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Bhargava is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Bhargava to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhargava practices. Vendor and product names are available with a free account.

Neurology is Dr. Bhargava's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Bhargava's licenses on file in 2 states: Maryland and Illinois.

CMS data shows 55 Medicare services from Dr. Bhargava across 3 procedure codes in 2024, for 60 Medicare patients. Medicare paid $5,742 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Bhargava in 2024. The largest group is 65 to 74, with 27 patients. 73% of them have high blood pressure, and 62% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhargava's median patient age at 54, with 75% women.

In 2024, Dr. Bhargava wrote 154 Medicare Part D claims for 17 patients. 100% of them were for generic drugs. CMS names the drug for 131 of them, across 5 drugs with 11 or more claims each, at $17,518 in total drug cost. In 2023, CMS named 121 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Bhargava for performance year 2024, reported as part of a group. CMS lists Dr. Bhargava as offering telehealth.

Dmand AI links 70 papers to Dr. Bhargava, published from 2013 to 2025. 2022 was the busiest year, with 7. The most frequent topics are Multiple Sclerosis, Brain and Inflammation. Dr. Bhargava has published most often in Mult Scler. Dr. Bhargava's most frequent co-authors are Peter Arthur Calabresi, MD, Ellen Mahar Mowry, MD and Shiv Saidha, MBCHB.

CMS Open Payments shows 60 general payments to Dr. Bhargava from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Novartis Pharmaceuticals Corporation paid the most, $30,000. It also lists 25 research payments totaling $2,421 from 2017 to 2025.